International Clinical Trial: Testing a new digital platform (ReMedi) to help people report and manage side effects from medicines

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000140358) titled 'Testing a new digital platform (ReMedi) to help people report and manage side effects from medicines' on Feb. 4.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Parallel

Primary Sponsor: Adelaide University

Condition: Adverse Drug Events Adverse Drug Events Public Health - Health service research

Intervention: The intervention involves consumers using a digital tool (ReMedi) to report any new symptoms or suspected adverse drug events (ADEs) they may experience after commencing on a medicine that is new to th...